Yahoo Web Search

Search results

1. • 

     UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent

     Benzinga via Yahoo Finance· 1 year ago

     The UK's Medicines and Healthcare Regulatory Agency (MHRA) warned of some new and severe eye-related...

2. • 

     Is Sanofi on the Verge of Another Blockbuster?

     Motley Fool· 2 years ago

     The U.S. Food and Drug Administration (FDA) recently announced that it had accepted Sanofi (NASDAQ: SNY) and Regeneron's (NASDAQ: REGN) supplemental...

3. • 

     Regeneron, Sanofi Plot A Major Expansion That Could Add $4 Billion In Future Sales

     Investor's Business Daily· 5 months ago

     Regeneron Pharmaceuticals and Sanofi said Monday their blockbuster drug, Dupixent, significantly...

4. • 

     Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars

     Investor's Business Daily· 1 year ago

     Sanofi and Regeneron Pharmaceuticals' asthma drug Dupixent succeeded in a final-phase study of...

5. • 

     Regeneron, Sanofi to seek new Dupixent approval in US after COPD success

     BioPharma Dive via Yahoo Finance· 5 months ago

     Results from the second of two Phase 3 trials testing the blockbuster drug in the respiratory...

6. • 

     FDA Approves the First Oral Treatment for Eosinophilic Esophagitis

     Verywell Health via Yahoo News· 3 months ago

     Verywell / Julie Bang Fact checked by Nick Blackmer Key Takeaways The FDA approved Takeda’s Eohilia,...

7. • 

     The Unexpectedly Good News That Helped Regeneron Retake Its 200-Day Line

     Investor's Business Daily· 9 months ago

     Regeneron Pharmaceuticals predicted a faster-than-expected approval timeline for a high dose of its...

8. • 

     UK regulator calls for review of reactions in eyes to Sanofi asthma drug

     Reuters via Yahoo News· 1 year ago

     The UK's Medicines and Healthcare products Regulatory Agency said most ocular reactions seen with...

9. • 

     Sanofi's New Cancer Drug Could Help Deliver a Big Payday

     Motley Fool via Yahoo Finance· 3 days ago

     Sanofi (NASDAQ: SNY) believes it has a potential blockbuster in its innovative new cancer-fighting...

10. • 

      Opinion: This law would stop insurers from putting profit over patients

      Deseret News via Yahoo News· 6 months ago

      Non-medical switching is the practice of compelling a stable patient to change medications for...